Parameters | Group I | Group II | Group III | P value |
---|---|---|---|---|
Pre-op AVRR | .792 ± .176 | .753 ± .171 | .696 ± .148 | .092 |
Post-op AVHR | .835 ± .159 | .859 ± .175 | .826 ± .103 | .546 |
Anterior VHRR | .043 ± .066 | .106 ± .069 | .130 ± .110 | .007* |
 Group I–II | .007* | |||
 Group I–III | .000* | |||
 Group II–III | .280 | |||
Pre-op CA (°) | 6.51 ± 11.47 | 6.84 ± 8.05 | 10.30 ± 8.37 | .200 |
Post-op CA (°) | 4.84 ± 11.33 | 4.23 ± 7.82 | 6.07 ± 6.82 | .672 |
CR | 1.66 ± 2.47 | 2.61 ± 2.42 | 4.24 ± 4.08 | .089 |
 Group I–II | .241 | |||
 Group I–III | .019* | |||
 Group II–III | .048* | |||
BV (ml) | 4.15 ± 1.25 | 5.46 ± 2.05 | 8.43 ± 2.20 | .000* |
 Group I–II | .000* | |||
 Group I–III | .000* | |||
 Group II–III | .000* | |||
BE occurrence | 0/17 | 4/22 | 16/43 | NA |
 Group I–II | .140 | |||
 Group I–III | .016* | |||
 Group II–III | .240 |